Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Clinical trial NCT06997094 · RECRUITING

Trial details

NCT number: NCT06997094
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma Resectable Head and Neck Squamous Cell Carcinoma Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma HPV-Negative Squamous Cell Carcinoma Resectable Head and Neck Squamous-cell Carcinoma

Start date: 2026-01-23
Primary completion: 2027-11-08
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.